Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

One-Third Of Consumers Ignore DTC Print Ad Brief Summary - FDA Survey

Executive Summary

Approximately one-third of consumers ignore the brief summary information that accompanies print DTC advertisements, according to FDA's survey "Attitudes and Behaviors Associated with Direct-To-Consumer Promotion of Prescription Drugs."

You may also be interested in...



DTC Ads Are "Most Accurate" Rx Info Source Due To FDA Oversight - PhRMA

FDA regulation helps ensure that direct-to-consumer ads are the most reliable prescription drug information available, the Pharmaceutical Research & Manufacturers of America maintains.

DTC Ads Are "Most Accurate" Rx Info Source Due To FDA Oversight - PhRMA

FDA regulation helps ensure that direct-to-consumer ads are the most reliable prescription drug information available, the Pharmaceutical Research & Manufacturers of America maintains.

DTC survey

FDA plans to survey physicians on direct-to-consumer advertising as follow-up to its 1999 consumer survey (1"The Pink Sheet" Jan. 24, 2000, p. 11). The agency will also conduct a follow-up survey of 775 patients. The physician portion of the study will investigate "DTC-related patient interactions, perceived patient outcomes, attitudes toward appropriate DTC categories, and general opinions about DTC advertising," FDA said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel